Risk Assessment for BK Virus-Associated Hemorrhagic Cystitis After Pediatric Hematopoietic Stem Cell Transplant: A Single-Center Retrospective Cross-Sectional Study

Sadeleştirilmiş öğe sayfası
dc.contributor.authorKaragun, Barbaros Sahin
dc.contributor.authorAygunes, Utku
dc.contributor.authorEken, Alper
dc.contributor.authorAkbas, Tugana
dc.contributor.authorMelek, Engin
dc.contributor.authorAntmen, Bulent
dc.date.accessioned2025-10-16T15:12:27Z
dc.date.issued2024
dc.identifier.doi10.6002/ect.2021.0104
dc.identifier.otherWOS:001427201100001
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/5448
dc.publisherBASKENT UNIV
dc.sourceEXPERIMENTAL AND CLINICAL TRANSPLANTATION
dc.subjectAllogeneic hematopoietic stem cell transplant
dc.subjectCyclophosphamide therapy
dc.titleRisk Assessment for BK Virus-Associated Hemorrhagic Cystitis After Pediatric Hematopoietic Stem Cell Transplant: A Single-Center Retrospective Cross-Sectional Study
dc.typeArticle

Dosyalar

Koleksiyonlar

WOS